Fundz

DiaGen AI, Inc. secures a 630,000 share equity stake in Nasdaq:MEDS, equivalent to 9.9% of the company valued at over $400,000. This partnership aims to discover novel cancer targets and develop an anti-cancer peptide pipeline.

PRIVATENov 18, 2026

Round Type

Venture

VancouverBiotechnologyArtificial IntelligenceTherapeuticsMachine Learning

Description

DiaGen AI, Inc. has partnered with Datameds AI (NASDAQ:MEDS) to leverage AI in the discovery of cancer targets. Through this collaboration, DiaGen earns a significant equity stake valued at over $400,000. The partnership provides access to an extensive primary tumor biobank for therapeutic target discovery and validation

Quick answer

DiaGen AI raised an undisclosed amount in a funding round, dated November 18, 2026. DiaGen AI is based in Vancouver, British Columbia, Canada.

How much did DiaGen AI raise?
DiaGen AI raised an undisclosed amount in a funding round on November 18, 2026.
What does DiaGen AI do?
DiaGen AI, Inc. is a Vancouver-based AI-driven tech-bio company specializing in proprietary AI tools and platforms for small molecule and peptide discovery.
Where is DiaGen AI based and how big is it?
DiaGen AI is based in Vancouver, British Columbia, Canada.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as DiaGen AI that raised within 45 days of this round, from Fundz verified event records.

  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • ChronoScale Holdings Corp raised $153M (Series C) on November 18, 2026.
  • Tesorai raised $5.3M (Seed) on November 18, 2026.
  • Soombit AI raised $9M (Series A) on November 17, 2026.
  • TestDynamics raised $9M (Series A) on November 16, 2026.
  • Boston Medical Sciences raised $35M (Series B) on November 13, 2026.

Who to call at DiaGen AI, and when

A new round usually means DiaGen AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DiaGen AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DiaGen AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DiaGen AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DiaGen AI

Location

Vancouver, British Columbia, Canada

About

DiaGen AI, Inc. is a Vancouver-based AI-driven tech-bio company specializing in proprietary AI tools and platforms for small molecule and peptide discovery. The company focuses on the discovery of novel cancer targets and developing anti-cancer peptide pipelines. They have access to one of the world’s largest primary tumor biobanks for therapeutic target validation. DiaGen aims to enhance drug response predictions by leveraging primary tumor features in their research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DiaGen AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for DiaGen AI's next move

See what Strategic adds

DiaGen AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.